NeuroSense Therapeutics
NRSN
NRSN
5 hedge funds and large institutions have $380K invested in NeuroSense Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$228K | |
| 2 | +$168K | |
| 3 | +$47.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.02K |
Top Sellers
No sellers this quarter